pyricoxib

a cyclooxygenase-2 inhibitor; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Neoplasms (Cancer) 12/01/2016 - "The novel PET radiotracer [(18)F]Pyricoxib displays a promising radiopharmacological profile to study COX-2 expression in cancer in vivo." 12/01/2016 - "Selective COX-2-mediated tumor uptake of [(18)F]Pyricoxib in HCA-7 xenografts was confirmed in vivo. "
2.	Colorectal Neoplasms (Colorectal Cancer) 12/01/2016 - "Uptake of [(18)F]Pyricoxib was assessed in human colorectal cancer cell lines HCA-7 (COX-2 positive) and HCT-116 (COX-2 negative). " 12/01/2016 - "Herein, we describe the radiopharmacological analysis of [(18)F]Pyricoxib, a novel radiolabeled COX-2 inhibitor, for specific PET imaging of COX-2 in colorectal cancer. "

1.	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)